[Oxcarbazepine-induced encephalopathy].
D000328:Adult; D000927:Anticonvulsants / Q000009:adverse effects*; D000962:Antimalarials / Q000009:adverse effects; D002220:Carbamazepine / Q000009:adverse effects* / Q000031:analogs & derivatives*; D002738:Chloroquine / Q000009:adverse effects; D003221:Confusion / Q000139:chemically induced; D004827:Epilepsy / Q000139:chemically induced / Q000188:drug therapy; D005260:Female; D006801:Humans; D007010:Hyponatremia / Q000139:chemically induced; D020258:Neurotoxicity Syndromes / Q000209:etiology*; D000078330:Oxcarbazepine; D002727:Proguanil / Q000009:adverse effects
D000927:Anticonvulsants; D000962:Antimalarials; D002220:Carbamazepine; D002738:Chloroquine; D002727:Proguanil; D000078330:Oxcarbazepine